The Latest Breaking News from Kritika SarmahHer

Despite an impressive first quarter earnings report, shares of Advanced Micro Devices (AMD) are in a downward spiral. Let's delve into the intricacies of AMD's current market dynamics to uncover the underlying reasons behind this unexpected turn of events.

With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…

As Microsoft (MSFT) gears up to announce its earnings on April 25, investors are eagerly awaiting to see if the tech giant will continue to impress. Despite its robust emphasis on cloud services and strategic AI investments, MSFT's recent downturns in personal and gaming revenues have sparked concerns. Is MSFT…

Anticipation is high in the market this week as investors look forward to Meta Platforms (META) unveiling its first-quarter results on Wednesday, April 24th. With bullish analysts' estimates and historic announcements, could META be on the verge of market momentum? Let us find out.

The first-quarter performance of The Charles Schwab Corporation (SCHW) has attracted considerable investor attention. But what lies beneath the surface? Let's dissect its fundamentals to ascertain whether it presents an enticing buying opportunity amidst today's market intricacies.

As technological advancements and investments increase, the chip industry anticipates significant benefits. While industry giants NVIDIA (NVDA) and Taiwan Semiconductor Manufacturing Company (TSM) are poised to capitalize on industry tailwinds, let's analyze which of these stocks is set for success in the second quarter.

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading.

In the dynamic landscape of semiconductor investments, two prominent industry players, Advanced Micro Devices (AMD) and QUALCOMM (QCOM), vie for investor attention. With the semiconductor industry poised for substantial growth driven by robust chip demand across diverse sectors and bolstered by supportive government initiatives, both companies stand to benefit. However,…

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…